Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Rating of “Hold” by Brokerages

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received a consensus rating of “Hold” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, one has issued a buy recommendation and two have given a strong buy recommendation to the company.

A number of equities analysts have recently commented on the company. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a research report on Monday, October 13th. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft raised Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a report on Monday, December 15th. Finally, Citigroup reiterated a “sell” rating on shares of Straumann in a report on Wednesday, January 14th.

Straumann Price Performance

SAUHY opened at $12.19 on Thursday. The business has a fifty day moving average price of $11.94 and a 200 day moving average price of $11.94. Straumann has a 12 month low of $10.30 and a 12 month high of $15.07.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.